Company page

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. is a publicly traded company on the American market, with a market capitalization of approximately $819.5 million. The company focuses on developing and commercializing innovative therapies for patients with cardiovascular diseases. Esperion is dedicated to addressing unmet medical needs through its research and product offerings.